Summary
Recently, the presence of small dense low density lipoprotein (LDL) has been postulated to be a stronger risk factor for coronary heart disease than large LDL. While small dense LDL has been associated with individual components of the insulin resistance syndrome such as hypertension, high triglyceride level, low high density (HDL) cholesterol, and diabetess mellitus, there has been little work exploring whether LDL size is decreased in subjects with multiple metabolic disorders. We examined the association of LDL size and pattern to specific insulin (which does not cross-react with proinsulin), proinsulin, increased triglyceride, decreased HDL, hypertension and impaired glucose tolerance in 488 non-diabetic subjects from the San Antonio Heart Study. LDL size was significantly related to specific insulin, proinsulin and the fasting proinsulin/insulin ratio. Small dense LDL was significantly associated with high triglyceride level, decreased HDL cholesterol, hypertension and impaired glucose tolerance. LDL size (å) decreased in a stepwise fashion with increasing number of the metabolic disorders described above (zero 262.6±9.4; one 257.0±9.3; two 256.4±9.4; three 249.0±9.1; and four 244.9±9.0). These results were similar in men and women and in non-Hispanic whites and Mexican Americans. The association between LDL size and the number of metabolic disorders remained statistically significant even after adjustment for obesity, body fat distribution, gender, ethnicity, proinsulin and insulin concentrations. Furthermore, decreases in LDL size are also significantly associated with both a selective beta-cell defect (as estimated by the fasting proinsulin/insulin ratio) and insulin resistance (as estimated by the fasting insulin concentrations) although the association was some-what stronger for the latter. We conclude that small dense LDL may form part of the insulin resistance syndrome in non-diabetic subjects.
Article PDF
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- LDL:
-
low density lipoprotein
- HDL:
-
high density lipoprotein
- IGT:
-
impaired glucose tolerance
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- WHR:
-
waist-hip ratio
References
Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel W (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Heart Study. JAMA 256: 2835–2838
Kannel W, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 74: 1–12
Shen MMS, Krauss RM, Lindgren FT, Forte TM (1981) Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 22: 236–244
Krauss RM, Burke DJ (1984) Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23: 97–104
Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917–1921
Crouse JR, Parks JS, Schey HM, Kahl FT (1985) Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26: 566–574
Campos H, Genest JJ, Blijlevens E et al. (1992) Low density lipoprotein particle size and coronary artery disease. Arteriosclerosis 12: 187–195
Modan M, Halkin H, Almog S et al. (1985) Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75: 809–817
Zavaroni I, Bonora E, Pagliara M et al. (1989) Risk factors for coronary artery disease in healthy persons with hyperin-sulinaemia and normal glucose tolerance. N Engl J Med 320: 702–706
Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326–337
Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK (1988) Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37: 338–345
DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerotic cardiovascular disease. Diabetes Care 14: 173–194
Ferrannini E, Buzzigoli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357
Garg A, Gelderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P (1988) Relationship between lipoprotein levels and in vivo insulin action in normal white men. Metabolism 37: 982–987
Abbott WGH, Lillioja S, Young AA et al. (1987) Relationship between plasma lipoprotein concentrations and insulin concentrations and insulin action in an obese hyperinsulinaemic population. Diabetes 36: 897–904
Reaven GM (1988) Banting Lecture 1988. Role of insulin resistance in human disease. 37: 1595–1607
Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analyses of the insulin resistance syndrome (syndrome X). Diabetes 41: 715–722
MykkÄnen L, Kuusisto J, PyörÄlÄ K, Laakso M (1993) Cardiovascular risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 36: 553–559
Haffner SM, MykkÄnen L, Valdez RA, Paidi M, Stern MP, Howard BV (1993) Low density lipoprotein size and subclass pattern in a biethnic population. Arterioscler Thromb 13: 1623–1630
Selby JV, Austin MA, Newman B et al. (1993) LDL subclass pattern and the insulin resistance syndrome in women. Circulation 88: 381–387
Reaven GM, Chen YDI, Jeppesen J, Mabeux P, Krauss RM (1993) Insulin resistance and hyperinsulinaemia in individuals with small dense low density lipoprotein particles. J Clin Invest 92: 141–146
Barakat HA, Carpenter JW, McLendon VD et al. (1990) Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinaemia and atherosclerosis. Diabetes 39: 1527–1533
Schaefer EJ, McNamara JR, Genest J et al. (1987) LDL particle size, lipoproteins and apolipoproteins in premature coronary disease: confounding effects of Β blockers. Circulation 76 [Suppl IV]: IV-531 (Abstract)
Haffner SM, MykkÄnen L, Stern MP, Paidi M, Howard BV (1994) Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17: 1164–1171
Feingold KR, Grunfeld C, Coerrier W, Krauss RM (1992) LDL subclass phenotypes and triglyceride metabolism in non-insulin dependent diabetes. Arterioscler Thromb 12: 1496–1502
Temple RC, Clark P, Schneider A, Nagi DK, Yudkin JS, Hales CN (1989) Insulin deficiency in non-insulin dependent diabetes. Lancet I: 293–295
Temple RC, Clark P, Schneider A, Nagi DK, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol 32: 689–693
Ward WK, LaCova EC, Paquette TL, Beard JC, Wallum BJ, Porte D (1987) Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698–702
Porte D (1991) Banting Lecture 1990. Β cells in type II diabetes mellitus. Diabetes 40: 166–180
Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamato Y (1988) Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31: 355–360
Saad MF, Kahn SE, Nelson RG et al. (1990) Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70: 1247–1253
Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN (1993) Insulin deficiency rather than hyperinsulinaemia in newly diagnosed type II diabetes mellitus. Diabetic Med 10: 305–312
Reaven GM, Chen YDI, Hollenbeck CB, Hseuh WH, Ostrega D, Polonsky KS (1993) Plasma insulin, C-peptide, and proinsulin concentrations in obese and non-obese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 76: 44–48
Davies M, Rayman G, Gray IP, Day JL, Hales CN (1993) Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diab Med 10: 313–320
Nagi DK, Hendra TJ, Ryle AJ et al. (1990) The relationship of concentrations of insulin, intact proinsulin, and 32–33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33: 532–537
Haffner SM, MykkÄnen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR (1993) Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects. Diabetes 42: 1297–1302
MykkÄnen L, Rönnemaa M, Laakso M (1994) Low insulin sensitivity is associated with a clustering of cardiovascular risk factors. Diabetes 43 [Suppl 1]: 152A (Abstract)
Hazuda HP, Comeaux PJ, Stern MP et al. (1986) A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol 123: 96–112
Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ (1984) Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120: 834–851
Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK (1986) Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 315: 220–224
Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP (1991) Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 14: 102–108
Bowsher RR, Wolny JD, Frank BH (1992) A rapid and sensitive immunoassay for the measurement of proinsulin in human serum. Diabetes 41: 1084–1090
World Health Organization Expert Committee (1985) Diabetes mellitus. WHO Technical Report, Series No. 727. Report of a WHO Study Group, World Health Organization, Geneva
Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK, Malina R (1980) Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obesity 10: 493–502
Hypertension detection and follow-up program cooperative group (1976) The hypertension detection and follow-up program. Prev Med 5: 207–215
Joint national committee on detection, evaluation and treatment of high blood pressure (1993) The fifth report of the joint national committee on detection, evaluation and treatment of high blood pressure (JNC V). Arch Intern Med 153: 154–183
Summary of the second report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol (adult treatment panel II) (1993) Expert panel on detection, evaluation and treatment of high blood cholesterol. JAMA 209: 3015–3023
Haffner SM, MykkÄnen L, Valdez RA et al. (1994) Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 79: 1806–1810
Hollenbeck CB, Chen N, Chen YDI, Reaven GM (1984) Relationship between plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes 33: 460–463
MykkÄnen L, Haffner SM, Rönnemaa T, Bergman R, Leino A, Laakso M (1994) Is there any difference in the association of plasma insulin levels and insulin sensitivity with serum lipids and lipoproteins? Metabolism 43: 599–603
Hunt SC, Wu LL, Hopkins PN et al. (1988) Apolipoproteins, low density lipoprotein subfraction and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidaemic hypertension. Arteriosclerosis 9: 335–344
Austin MA, MykkÄnen L, Kuusisto J et al. (1994) Small, dense low density lipoprotein (LPL) and elevated triglyceride (TG) prospectively predict non-insulin dependent diabetes mellitus (NIDDM) in the elderly. Circulation 40 [Part 2]: 1460 (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haffner, S.M., MykkÄnen, L., Robbins, D. et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38, 1328–1336 (1995). https://doi.org/10.1007/BF00401766
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00401766